Treatment Plan for Moderate to Severe Depression in Adults
For adults with moderate to severe depression, initiate treatment with either cognitive-behavioral therapy (CBT) or a second-generation antidepressant (such as fluoxetine 20 mg daily), based on patient preference, access to mental health services, and tolerability concerns. 1
Initial Treatment Selection
First-Line Options
- CBT and second-generation antidepressants show similar efficacy for moderate to severe depression, so the choice should prioritize patient preference, availability of trained therapists, and adverse effect profiles 1
- Individual CBT delivered by licensed mental health professionals should include cognitive restructuring, behavioral activation, problem-solving strategies, and relapse prevention components 1, 2
- Pharmacotherapy is appropriate for patients without access to psychological treatment, those preferring medication, patients with prior positive medication response, or those with severe symptoms or psychotic features 1
Specific CBT Components
- Cognitive restructuring helps patients identify and modify inaccurate thinking patterns associated with emotional distress 2
- Behavioral activation increases engagement in activities providing accomplishment or pleasure, particularly effective for patients with less severe initial symptoms 2, 3
- Problem-solving treatment should be offered as individual or adjunct therapy in moderate to severe cases 1
- Avoid core belief work early in treatment, as this strategy is associated with subsequent symptom increases rather than improvement 3
Pharmacotherapy Details
Medication Selection
- Start fluoxetine 20 mg daily in the morning as the initial dose for most adults, as this is sufficient for satisfactory response in major depression 4
- Consider dose increases after several weeks if insufficient improvement occurs, with maximum dosing up to 80 mg/day 4
- For patients concerned about sexual dysfunction, vortioxetine may be preferable due to lower rates of this adverse effect 5
- SNRIs like venlafaxine show slightly better symptom improvement than SSRIs but have higher rates of nausea, vomiting, and discontinuation due to adverse effects 5
Monitoring Requirements
- Assess for suicidal ideation, agitation, irritability, and unusual behavioral changes within 1-2 weeks of starting antidepressants, particularly in patients under age 25 5, 6
- Evaluate treatment response at 4-8 weeks using standardized validated instruments 1, 5
- Monitor venlafaxine patients for blood pressure elevation, especially at higher doses 5
Treatment Response Assessment
Regular Monitoring Schedule
- Assess symptom relief, side effects, and patient satisfaction at 4 and 8 weeks for both pharmacologic and psychological interventions 1
- If symptoms are stable or worsening after 8 weeks despite good adherence, adjust the regimen by adding a psychological or pharmacologic intervention, changing medication, or switching from group to individual therapy 1
Expected Timeline
- Full antidepressant effect may be delayed until 4 weeks or longer of treatment 4
- CBT typically requires 8-14 sessions delivered over several weeks to months 1, 7
Treatment Duration
Continuation Phase
- Continue treatment for 4-9 months after satisfactory response in patients with first-episode major depression 5
- Antidepressant treatment should not be stopped before 9-12 months after recovery to prevent relapse 1
- For patients with two or more depressive episodes, consider years to lifelong maintenance treatment 5
Combination Therapy
When to Combine Approaches
- Combination of CBT and antidepressants may increase response rates and extend durability, particularly effective for severe or chronic depression 7, 8
- Add structured physical activity programs as adjunct treatment in moderate to severe cases 1
- Consider psychosocial group interventions covering stress reduction, positive coping, and social support enhancement 1
Common Pitfalls to Avoid
- Do not use antidepressants for mild depressive episodes as initial treatment; reserve for moderate to severe cases 1
- Avoid premature discontinuation of antidepressants before 9-12 months, as this increases relapse risk 1
- Do not assume all second-generation antidepressants are equivalent in tolerability; venlafaxine has higher discontinuation rates than SSRIs 5
- Ensure therapist competence in CBT, as this significantly influences treatment outcomes 7